Literature DB >> 8921006

Asp-49 is not an absolute prerequisite for the enzymic activity of low-M(r) phospholipases A2: purification, characterization and computer modelling of an enzymically active Ser-49 phospholipase A2, ecarpholin S, from the venom of Echis carinatus sochureki (saw-scaled viper).

J Polgár1, E M Magnenat, M C Peitsch, T N Wells, K J Clemetson.   

Abstract

Several studies have shown that Asp-49 is the residue that controls calcium binding in, and so plays a critical role in the calcium-mediated activation of, low-M(r) group I-III phospholipases A2 (PLA2s). The present paper provides experimental evidence that Asp-49 is not an absolute prerequisite for the enzymic activity of PLA2s, and that proteins with amino acid(s) other than Asp at position 49 can exhibit significant phospholipase activity. The purification, complete amino acid sequence and characterization of ecarpholin S, a PLA2 from Echis carinatus sochureki (saw-scaled viper) venom, is described. This single-chain, 122-amino-acid, basic (pI 7.9) protein is a group II PLA2. Although Asp-49 is replaced by Ser and Tyr-28 by Phe (both of these positions being involved in the Ca(2+)-binding site of PLA2s), the lipolysis of soybean phosphatidylcholine and egg yolk in the presence of 10 mM CaCl2 was 1.5 times and 2.9 times greater respectively with ecarpholin S than with recombinant human group II PLA2. The Ca(2+)-dependencies of the enzymic activities of ecarpholin S and rPLA2 were found to be similar. Ecarpholin S added to washed platelets induced aggregation; the presence of Ca2+ was a prerequisite for this platelet-aggregating effect. Computer modelling of the Ca(2+)-binding site of Ser-49 PLA2 compared with the Asp-49 and Lys-49 forms, for which crystallographic data exist, shows that the Ca(2+)-binding site is sterically blocked by Lys-49 but not by Ser-49; in the latter, the Ser hydroxy group may replace the Asp carboxylate in stabilization of Ca2+ binding. Sequence comparisons of ecarpholin S and other low-M(r) PLA2s predicts the presence of a Ser-49 group in the protein family of low-M(r) PLA2s that is distinct from the Asp-49 and Lys-49 groups.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921006      PMCID: PMC1217882          DOI: 10.1042/bj3190961

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  51 in total

1.  Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue.

Authors:  S P White; D L Scott; Z Otwinowski; M H Gelb; P B Sigler
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

2.  Purification and amino acid sequence of basic protein II, a lysine-49-phospholipase A2 with low activity, from Trimeresurus flavoviridis venom.

Authors:  S Y Liu; K Yoshizumi; N Oda; M Ohno; F Tokunaga; S Iwanaga; H Kihara
Journal:  J Biochem       Date:  1990-03       Impact factor: 3.387

3.  Platelet aggregation measured by the photometric method.

Authors:  M B Zucker
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

4.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Cleavage of the NH2-terminal octapeptide of Bothrops asper myotoxic lysine-49 phospholipase A2 reduces its membrane-destabilizing effect.

Authors:  C Díaz; A Alape; B Lomonte; T Olamendi; J M Gutiérrez
Journal:  Arch Biochem Biophys       Date:  1994-08-01       Impact factor: 4.013

7.  The amino acid sequence and properties of an edema-inducing Lys-49 phospholipase A2 homolog from the venom of Trimeresurus mucrosquamatus.

Authors:  C S Liu; J M Chen; C H Chang; S W Chen; C M Teng; I H Tsai
Journal:  Biochim Biophys Acta       Date:  1991-04-29

8.  Structural elements of secretory phospholipases A2 involved in the binding to M-type receptors.

Authors:  G Lambeau; P Ancian; J P Nicolas; S H Beiboer; D Moinier; H Verheij; M Lazdunski
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

9.  cDNA cloning and sequence analysis of a lysine-49 phospholipase A2 myotoxin from Agkistrodon contortrix laticinctus snake venom.

Authors:  H S Selistre de Araujo; S P White; C L Ownby
Journal:  Arch Biochem Biophys       Date:  1996-02-01       Impact factor: 4.013

10.  Crystallographic and biochemical studies of the (inactive) Lys-49 phospholipase A2 from the venom of Agkistridon piscivorus piscivorus.

Authors:  D L Scott; A Achari; J C Vidal; P B Sigler
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

View more
  10 in total

1.  Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa.

Authors:  Juan J Calvete; Pedro Cid; Libia Sanz; Alvaro Segura; Mauren Villalta; María Herrera; Guillermo León; Robert Harrison; Nandul Durfa; Abdusalami Nasidi; R David G Theakston; David A Warrell; José María Gutiérrez
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

2.  Structural characterization of myotoxic ecarpholin S from Echis carinatus venom.

Authors:  Xingding Zhou; Tien-Chye Tan; S Valiyaveettil; Mei Lin Go; R Manjunatha Kini; Adrian Velazquez-Campoy; J Sivaraman
Journal:  Biophys J       Date:  2008-06-27       Impact factor: 4.033

3.  Characterization of crude Echis carinatus venom-induced cytotoxicity in HEK 293T cells.

Authors:  Rebecca D Pierce; Ethan S Kim; Lance W Girton; Jonathan L McMurry; Joshua W Francis; Eric A Albrecht
Journal:  J Venom Res       Date:  2011-12-28

Review 4.  Alpha-type phospholipase A2 inhibitors from snake blood.

Authors:  Norival A Santos-Filho; Claudia T Santos
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-03-23

Review 5.  Insights into the antiviral activity of phospholipases A2 (PLA2s) from snake venoms.

Authors:  S C Teixeira; B C Borges; V Q Oliveira; L S Carregosa; L A Bastos; I A Santos; A C G Jardim; F F Melo; L M Freitas; V M Rodrigues; D S Lopes
Journal:  Int J Biol Macromol       Date:  2020-07-19       Impact factor: 6.953

6.  Contextual Constraints: Dynamic Evolution of Snake Venom Phospholipase A2.

Authors:  Vivek Suranse; Timothy N W Jackson; Kartik Sunagar
Journal:  Toxins (Basel)       Date:  2022-06-20       Impact factor: 5.075

7.  Induction of mast-cell accumulation by promutoxin, an Arg-49 phospholipase A2.

Authors:  Ji-Fu Wei; Xiao-Long Wei; Ya-Zhen Mo; Haiwei Yang; Shaoheng He
Journal:  Biomed Res Int       Date:  2012-12-20       Impact factor: 3.411

Review 8.  Antitumoral potential of Tunisian snake venoms secreted phospholipases A2.

Authors:  Raoudha Zouari-Kessentini; Najet Srairi-Abid; Amine Bazaa; Mohamed El Ayeb; Jose Luis; Naziha Marrakchi
Journal:  Biomed Res Int       Date:  2013-01-31       Impact factor: 3.411

9.  Molecular characterization of Lys49 and Asp49 phospholipases A₂from snake venom and their antiviral activities against Dengue virus.

Authors:  Alzira B Cecilio; Sergio Caldas; Raiana A De Oliveira; Arthur S B Santos; Michael Richardson; Gustavo B Naumann; Francisco S Schneider; Valeria G Alvarenga; Maria I Estevão-Costa; Andre L Fuly; Johannes A Eble; Eladio F Sanchez
Journal:  Toxins (Basel)       Date:  2013-10-15       Impact factor: 4.546

10.  Proteomics and antivenomics of Echis carinatus carinatus venom: Correlation with pharmacological properties and pathophysiology of envenomation.

Authors:  Aparup Patra; Bhargab Kalita; Abhishek Chanda; Ashis K Mukherjee
Journal:  Sci Rep       Date:  2017-12-07       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.